Literature DB >> 11963295

[Cytochrome P450 enzymes and their role in drug interactions].

C Papp-Jámbor1, U Jaschinski, H Forst.   

Abstract

One of the factors that can alter the response to drugs is the concurrent administration of other drugs. There are several mechanisms by which drugs may interact, but most can be categorised as pharmacokinetic (absorption, distribution, metabolism, excretion), pharmacodynamic, or combined toxicity. Knowledge of the mechanism by which a given drug interaction occurs is often clinically useful and may help to avoid serious adverse events and perioperative morbidity. Although every tissue has some ability to metabolise drugs, the liver is the principal organ of drug metabolism and at the subcellular level the cytochrome P450 enzyme system is the main source of drug interaction. This article reviews the basic principles of drug metabolism and the role of cytochrome P450 in this scenario. Drugs frequently used in anaesthesia and critical care medicine such as benzodiazepines, opioid analgesics, antihypertensive and antiarrhythmic agents, antibiotics and antifungal drugs, antiemetics, histamine-receptor-antagonists, theopylline and paracetamol will be considered. The development of methods and tools which are practical and also economic, are of utmost importance since drug interaction is predictable if the metabolic pathway and the activity (genetic polymorphism) of the enzyme is known.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11963295     DOI: 10.1007/s101-002-8365-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  6 in total

Review 1.  [Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview].

Authors:  W Kämmerer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-23       Impact factor: 0.840

Review 2.  [New aspects of perioperative statin therapy].

Authors:  N Butte; B W Böttiger; O Liakopoulos; P Teschendorf
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

3.  Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives.

Authors:  Ying Zhao; Shiyuan Lin; Ruiyue Fang; Yaling Shi; Wei Wu; Wei Zhang; Hui Chen
Journal:  Int J Nanomedicine       Date:  2022-07-29

Review 4.  Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.

Authors:  Sarah C Preissner; Michael F Hoffmann; Robert Preissner; Mathias Dunkel; Andreas Gewiess; Saskia Preissner
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

5.  Design, synthesis, and in vitro and in vivo characterization of 1-{4-[4-(substituted)piperazin-1-yl]butyl}guanidines and their piperidine analogues as histamine H3 receptor antagonists.

Authors:  Marek Staszewski; Anna Stasiak; Tadeusz Karcz; Daniel McNaught Flores; Wiesława Agnieszka Fogel; Katarzyna Kieć-Kononowicz; Rob Leurs; Krzysztof Walczyński
Journal:  Medchemcomm       Date:  2019-01-11       Impact factor: 3.597

Review 6.  [Drug interactions and the anesthesiologist].

Authors:  A S Milde; J Motsch
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.